inky,
Its a difficult question. Up until the last year a lot of physicians thought all statins were created equal. However several trials in that time period showed that there was most likely a difference in the way these drugs work, despite having a similar mechanism of action in the body.
The problem with extrapolating these trials is that they only looked at 2 specific statin medications when there are several out there.
Mevacor is right stating it has been shown that it prevents heart attacks as it was shown to prevent heart attacks in a well designed prospective large trial. Some of the other statin medications can not make the same claims as they have only been tested in
safetyChild safety seats
Home safety
Safe driving for teens
Safety or soft endpoint trials designed to market the medication. These types of trials show that the medication lowers
lipidsCoronary risk profile
High blood cholesterol and triglycerides or other markers, but are not powered to show the primary mortality endpoints. You might have noticed on some of the comercials for statin medications there is a disclaimer statement saying 'this medication has not been shown to prevent heart attacks'
The bottom line from the more recent trials show that we have probably been too lax in treating cholesterol and that out targets for LDL cholesterol in the past have been too high. Further, it is becoming clear that other markers such as CRP are becoming important to follow and guide therapy. Current guidelines are evolving to reflect these changes.
I usually will not change a statin if a patient has very well controlled LDL and CRP levels. If not, I generally will consider switching to a higher dose of atorvastin based on the results of the recent trials using this medication. The whole process is quite confusing, and the information I have given you doesnt even reflect the growing recognition of the importance in HDL and other markers in the whole process. Over the next few years therapies that modify HDL will be available in addition to other potent markers of arterial inflammation such as MPO.
I think if you are having problems with side effects from your medication, or problems with poor efficacy of your current regimen it could potentially help to see a preventive cardiologist or lipid specialist.
good luck
I've been taking Zocor for two weeks now and so far no side effects whatsoever, but I take it every other day am scared to take it every day.
1. Crestor
2. Lipitor
3. Zocor
4. Pravachol
5. Others
Crestor may be pulled from the market because of a very small percentage of patients with life threatening side effects on high dosages.
I have taken 20 mg Lipitor for 4 years without noticing any side effects and have no liver problems. Instead of taking a high dose, I take 2 other drugs in combination and have maintained an excellent lipid profile over the last years.
Zocor is probably as good, but not quite as effective as Lipitor. HMOs prescribe it a lot because it's cheaper to them.
In my experience, Pravachol is about half as effective as Lipitor.
I think that the statins effectiveness are pretty well maxed out with Lipitor and Crestor. We won't see another new drug in that class.
The next drugs out will be CETP inhibitors to increase HDL which is really the problem with most CAD patients. They will save a lot of lives and, with daily exercise, will highly reduce the need for stenting and bypass surgery. Of course the medical profession will still overpractice these procedures because of the high revenues that they generate and their culture of denial about that situation.
Most people can avoid stenting or bypass surgery today and arrest their disease with agressive lipid therapy with multiple drugs available today and daily exercise.